JAN 16, 2020 8:11 AM PST

FLASH proton therapy: faster and more effective

A new technique called FLASH proposes a new type of radiation therapy. The technique is composed of an ultra-high dose rate of radiotherapy and uses electrons to minimize healthy tissue damage while targeting tumors. Conducted in mice models, FLASH is capable of administering radiation therapy in mere milliseconds, resulting in the same effects of typical radiation sessions but in a fraction of the time.

The research was published recently in the International Journal of Radiation Oncology, Biology, and Physics. Headed by co-author Dr. James M. Metz, director of the Roberts Proton Therapy Center and Chair of Radiation Oncology at the University of Pennsylvania, in Philadelphia, FLASH shows how powerful proton radiation can be and the potential it has to change cancer patients’ treatments.

Typical radiation therapy slows the progression of cancer by damaging cancer cells’ DNA or killing them; yet this process is a lengthy one, sometimes lasting multiple weeks because small doses are most effective at making sure that healthy cells are not targeted during treatment. Because over half of the people with a cancer diagnosis receive radiation therapy, identifying more effective forms of radiation therapy would greatly improve the quality of life for millions of people.

The idea to utilize protons instead of electrons in FLASH therapy stemmed from previous studies in mice that suggested proton therapy would allow for higher doses of radiation in a safer and more effective delivery method. To test this technique, the researchers developed a radiotherapy apparatus that could deliver FLASH or standard radiation dose rates "using double scattered protons in a [...] CT–defined geometry."

FLASH proton therapy proves to be effective in reducing the duration of radiation. Photo: Pixabay

They found that their design was successful at targeting pancreatic cancer flank tumors while reducing gastrointestinal damage in mice models. The team hopes to continue their research to eventually develop a technique that would deliver FLASH with protons to humans.

Dr. Metz expressed the team’s excitement over their development: "This is the first time anyone has published findings that demonstrate the feasibility of using protons — rather than electrons — to generate FLASH doses with an accelerator currently used for clinical treatments."

Sources: International Journal of Radiation Oncology, Biology, and Physics, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 27, 2020
Cancer
APR 27, 2020
The Tumor Suppressor and its Regulator: An Indirect Oncogene
Oncogenes, mutations in genes that promote cancer growth, have long been easy targets for cancer research due to the dir ...
MAY 12, 2020
Clinical & Molecular DX
MAY 12, 2020
Could Catching the Flu Be Linked to an Increased Cancer Risk?
Results from a new research study suggest that a spike in infections such as influenza could be linked to the risk of de ...
MAY 14, 2020
Cancer
MAY 14, 2020
New hope for immunotherapy for pediatric brain cancer
Pediatric brain cancer is an especially tough pill to swallow. While one in four children does not survive medulloblasto ...
JUN 22, 2020
Cancer
JUN 22, 2020
Methylation Markers That Can be Used to Diagnose Pancreatic Cancer
Diagnostic tests are the unsung heroes of cancer treatment. While there are more treatments for cancer coming out every ...
JUN 19, 2020
Cancer
JUN 19, 2020
Sedentary behavior associated with increased cancer mortality
A study published in JAMA Oncology reports findings that a greater amount of sedentary time was associated with a higher ...
JUN 10, 2020
Drug Discovery & Development
JUN 10, 2020
A Highly Targeted Cancer Therapeutic
A study led by researchers at USC School of Pharmacy discusses a way to engineer drugs that highly target malignant tiss ...
Loading Comments...